Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.84 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.58 |
| ▸ | CES2 | O00748 | 2/20 | 0.58 |
| ▸ | CES1 | P23141 | 2/20 | 0.58 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28451754 | 0.96 | NR4A1 (0.85) | NR4A1AKR1C3CES2CES1SRD5A2 | |
| SCHEMBL30114756 | 0.96 | NR4A1 (0.85) | NR4A1AKR1C3CES2CES1SRD5A2 | |
| SCHEMBL1247787 | 0.92 | NR4A1 (1.00) | NR4A1AKR1C3CES2CES1SRD5A2 | |
| SCHEMBL30884880 | 0.92 | NR4A1 (1.00) | NR4A1AKR1C3CES2CES1SRD5A2 | |
| SCHEMBL6299251 | 0.92 | NR4A1 (0.72) | NR4A1AKR1C3CES2CES1SRD5A2 | |
| SCHEMBL2175941 | 0.90 | NR4A1 (0.70) | NR4A1AKR1C3CES2CES1SRD5A2 | |
| SCHEMBL9495711 | 0.90 | NR4A1 (0.70) | NR4A1AKR1C3CES2CES1SRD5A2 | |
| SCHEMBL2991958 | 0.89 | NR4A1 (0.69) | NR4A1CES2CES1SRD5A2MAPK1 | |
| SCHEMBL29989484 | 0.89 | NR4A1 (0.69) | NR4A1CES2CES1SRD5A2MAPK1 | |
| SCHEMBL17713295 | 0.88 | NR4A1 (0.68) | NR4A1AKR1C3CES2CES1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110268003-B | Curable compound | 株式会社大赛璐 | 2022-08-09 | — | — | CN | disclosed |
| US-11021438-B2 | Curable compound | DAICEL CORPORATION (JP) | 2021-06-01 | — | — | US | disclosed |
| US-20200079726-A1 | CURABLE COMPOUND | DAICEL CORPORATION (JP) | 2020-03-12 | — | — | US | disclosed |
| CN-110462906-A | Amberplex, its manufacturing method and the energy storage device including it | KOLON INC | 2019-11-15 | — | — | CN | disclosed |
| EP-3556793-A1 | CURABLE COMPOUND | Daicel Corporation (JP) | 2019-10-23 | — | — | EP | disclosed |
| CN-107188790-A | A kind of preparation method of 1,4 2 (4 hydroxyl benzoyl group) benzene monomers | 沈阳化工大学 | 2017-09-22 | — | — | CN | disclosed |
| US-7816053-B2 | Membrane-electrode assembly for solid polymer electrolyte fuel cell | HONDA MOTOR CO., LTD. (JP) | 2010-10-19 | — | — | US | disclosed |
| US-20060280991-A1 | Membrane-electrode assembly for solid polymer electrolyte fuel cell | HONDA MOTOR CO., LTD. | 2006-12-14 | — | — | US | disclosed |
| US-5378770-A | Oligomerizing alkali metal sulfide and dihalobenzene; reacting with bis(halobenzoyl)benzene | KUREHA KAGAKU KOGYO K.K. (JP) | 1995-01-03 | — | — | US | disclosed |
| US-5378771-A | Sulfiding dihalobenzene and bis(halobenzoyl)benzene in two steps to copolymerize poly(arylene thioetherketoneketones) | KUREHA KAGAKU KOGYO K.K.K. (JP) | 1995-01-03 | — | — | US | disclosed |
| US-5250636-A | Poly(arylene thioether-ketone-ketone) copolymer and production process thereof | KUREHA KAGAKU KOGYO K.K. (JP) | 1993-10-05 | — | — | US | disclosed |
| US-5248743-A | Polythioethers | KUREHA KAGAKU KOGYO K.K. (JP) | 1993-09-28 | — | — | US | disclosed |
| EP-0459621-A2 | Poly(arylene thioether-ketone-ketone) copolymer and production process thereof | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-12-04 | — | — | EP | disclosed |
| EP-0435674-A2 | High-heat-resistant, crystalline block copolymers and production process thereof | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-07-03 | — | — | EP | disclosed |
| EP-0389902-A1 | Process for producing aromatic polyetherketones | BAYER AG (DE) | 1990-10-03 | — | — | EP | disclosed |
| EP-0374462-A2 | Process for preparing high molecular weight optionally branched polyarylene sulfides | BAYER AG (DE) | 1990-06-27 | — | — | EP | disclosed |
| US-4835242-A | Aryl ether ketones | BASF AKTIENGESELLSCHAFT (DE) | 1989-05-30 | — | — | US | disclosed |
| EP-0306051-A1 | Process for production of aromatic polyethers | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1989-03-08 | — | — | EP | disclosed |
| EP-0275037-A2 | Aryl ether ketones | BASF Aktiengesellschaft (DE) | 1988-07-20 | — | — | EP | disclosed |
| US-4105635-A | MANUFACTURE OF AROMATIC POLYMERS CONTAINING KETONE AND SULPHONE GROUPS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079726-A1 | CURABLE COMPOUND | CNOT1, CCNH, ASH2L | NR4A1 1246/4885AKR1C3 1849/4885CES2 1943/4885 |
| US-11021438-B2 | Curable compound | CNOT1, CCNH, ASH2L | NR4A1 1246/4885AKR1C3 1849/4885CES2 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.